Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation

Abstract There is growing evidence that autoantibodies (AAbs) against proteins expressed in the brain are playing an important role in neurological and psychiatric disorders. Here, we explore the presence and the role of peripheral AAbs to the α7-nicotinic acetylcholine receptor (nAChR) in inflammat...

Full description

Bibliographic Details
Main Authors: Estelle Darrau, Elise Jacquemet, Stéphanie Pons, Laurène Schlick, Marios Zouridakis, Ching-Lien Wu, Jean-Romain Richard, Caroline Barau, Philippe Le Corvoisier, Robert Yolken, Ryad Tamouza, Marion Leboyer, Uwe Maskos
Format: Article
Language:English
Published: Nature Publishing Group 2024-03-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-024-02853-8
_version_ 1797259036589031424
author Estelle Darrau
Elise Jacquemet
Stéphanie Pons
Laurène Schlick
Marios Zouridakis
Ching-Lien Wu
Jean-Romain Richard
Caroline Barau
Philippe Le Corvoisier
Robert Yolken
Ryad Tamouza
Marion Leboyer
Uwe Maskos
author_facet Estelle Darrau
Elise Jacquemet
Stéphanie Pons
Laurène Schlick
Marios Zouridakis
Ching-Lien Wu
Jean-Romain Richard
Caroline Barau
Philippe Le Corvoisier
Robert Yolken
Ryad Tamouza
Marion Leboyer
Uwe Maskos
author_sort Estelle Darrau
collection DOAJ
description Abstract There is growing evidence that autoantibodies (AAbs) against proteins expressed in the brain are playing an important role in neurological and psychiatric disorders. Here, we explore the presence and the role of peripheral AAbs to the α7-nicotinic acetylcholine receptor (nAChR) in inflammatory subgroups of psychiatric patients with bipolar disorder (BD) or schizophrenia (SCZ) and healthy controls. We have identified a continuum of AAb levels in serum when employing a novel ELISA technique, with a significant elevation in patients compared to controls. Using unsupervised two-step clustering to stratify all the subjects according to their immuno-inflammatory background, we delineate one subgroup consisting solely of psychiatric patients with severe symptoms, high inflammatory profile, and significantly increased levels of anti-nAChR AAbs. In this context, we have used monoclonal mouse anti-human α7-nAChR antibodies (α7-nAChR-mAbs) and shown that TNF-α release was enhanced upon LPS stimulation in macrophages pre-incubated with α7-nAChR-mAbs compared to the use of an isotype control. These findings provide a basis for further study of circulating nicotinic AAbs, and the inflammatory profile observed in patients with major mood and psychotic disorders.
first_indexed 2024-04-24T23:03:03Z
format Article
id doaj.art-d70c930053cb4950802636999a6aa666
institution Directory Open Access Journal
issn 2158-3188
language English
last_indexed 2024-04-24T23:03:03Z
publishDate 2024-03-01
publisher Nature Publishing Group
record_format Article
series Translational Psychiatry
spelling doaj.art-d70c930053cb4950802636999a6aa6662024-03-17T12:39:06ZengNature Publishing GroupTranslational Psychiatry2158-31882024-03-0114111310.1038/s41398-024-02853-8Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammationEstelle Darrau0Elise Jacquemet1Stéphanie Pons2Laurène Schlick3Marios Zouridakis4Ching-Lien Wu5Jean-Romain Richard6Caroline Barau7Philippe Le Corvoisier8Robert Yolken9Ryad Tamouza10Marion Leboyer11Uwe Maskos12Université Paris Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry LaboratoryInstitut Pasteur, Université de Paris Cité, Bioinformatics and Biostatistics HubInstitut Pasteur, Université de Paris Cité, Integrative Neurobiology of Cholinergic Systems, CNRS UMR 3571Institut Pasteur, Université de Paris Cité, Integrative Neurobiology of Cholinergic Systems, CNRS UMR 3571Laboratory of Molecular Neurobiology and Immunology, Hellenic Pasteur InstituteUniversité Paris Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry LaboratoryUniversité Paris Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry LaboratoryPlateforme de ressources biologiques, Hôpital Henri Mondor, Université Paris Est CréteilCentre d’Investigation Clinique 1430, AP-HP, Hôpital Henri Mondor, Université Paris Est CréteilStanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins School of MedicineUniversité Paris Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry LaboratoryUniversité Paris Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry LaboratoryInstitut Pasteur, Université de Paris Cité, Integrative Neurobiology of Cholinergic Systems, CNRS UMR 3571Abstract There is growing evidence that autoantibodies (AAbs) against proteins expressed in the brain are playing an important role in neurological and psychiatric disorders. Here, we explore the presence and the role of peripheral AAbs to the α7-nicotinic acetylcholine receptor (nAChR) in inflammatory subgroups of psychiatric patients with bipolar disorder (BD) or schizophrenia (SCZ) and healthy controls. We have identified a continuum of AAb levels in serum when employing a novel ELISA technique, with a significant elevation in patients compared to controls. Using unsupervised two-step clustering to stratify all the subjects according to their immuno-inflammatory background, we delineate one subgroup consisting solely of psychiatric patients with severe symptoms, high inflammatory profile, and significantly increased levels of anti-nAChR AAbs. In this context, we have used monoclonal mouse anti-human α7-nAChR antibodies (α7-nAChR-mAbs) and shown that TNF-α release was enhanced upon LPS stimulation in macrophages pre-incubated with α7-nAChR-mAbs compared to the use of an isotype control. These findings provide a basis for further study of circulating nicotinic AAbs, and the inflammatory profile observed in patients with major mood and psychotic disorders.https://doi.org/10.1038/s41398-024-02853-8
spellingShingle Estelle Darrau
Elise Jacquemet
Stéphanie Pons
Laurène Schlick
Marios Zouridakis
Ching-Lien Wu
Jean-Romain Richard
Caroline Barau
Philippe Le Corvoisier
Robert Yolken
Ryad Tamouza
Marion Leboyer
Uwe Maskos
Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
Translational Psychiatry
title Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
title_full Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
title_fullStr Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
title_full_unstemmed Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
title_short Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
title_sort serum autoantibodies against α7 nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia clinical features and link with peripheral inflammation
url https://doi.org/10.1038/s41398-024-02853-8
work_keys_str_mv AT estelledarrau serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT elisejacquemet serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT stephaniepons serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT laureneschlick serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT marioszouridakis serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT chinglienwu serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT jeanromainrichard serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT carolinebarau serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT philippelecorvoisier serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT robertyolken serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT ryadtamouza serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT marionleboyer serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation
AT uwemaskos serumautoantibodiesagainsta7nicotinicreceptorsinsubgroupsofpatientswithbipolardisorderorschizophreniaclinicalfeaturesandlinkwithperipheralinflammation